drugset / Trial / NCT01179529
Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage
NaSingle-groupTreatment
Summary
This study aims at evaluating the therapeutic potential of omalizumab in atopic dermatitis, and to work out biomarkers predictive of treatment response.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omalizumab | Monoclonal antibody | — | — |